Molecularly, high sensitivity of mutant and cancer cells with the OPC feature toward IGF1R targeting likely stems from the intimate coupling between IGF1R and PDGFRα, as the coexpression of both RTKs largely occurs in OPCs in the brain. The gene discussed is PDGFRA; the disease is cancer.